Millennial Man Told He Has Sinus Infection, Then Doctors Drop a Bombshell
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A man's life has been derailed after what seemed like a sinus infection turned out to be a devastating diagnosis that would leave him fighting for his life.
In 2024, Brian McNamara, 47, thought he'd developed a sinus infection because he had persistent symptoms that he couldn't shake for months. The teacher and football coach from New Jersey developed a sinus headache that continued to get worse as the months went by.
As it progressed, his symptoms escalated and became numerous. Hardly a day went by when he didn't feel in pain or discomfort.
McNamara's wife, Jodi, told Newsweek that, after a while, he went to urgent care where he was treated "for a sinus infection." Nonetheless, the symptoms persisted, and treatment wasn't working.
"It continued to worsen, and he started having ringing in his ears, a fullness feeling in the ears (like he was underwater), bad breath, neck pain, and jaw tightness," Jodi, 44, said. "Then, he got eventual facial numbness and double vision too.
Brian and Jodi McNamara pictured together in a hospital.
Brian and Jodi McNamara pictured together in a hospital.
@wintheinch_wintheday / TikTok
"It went from bad to worse two weeks prior to Thanksgiving, but looking back now, it was probably June when his symptoms started," she continued.
Given how bad his symptoms were, Brain returned to the ER after Thanksgiving. He was taken for an MRI and CT scan, which is when everything changed.
A mass was discovered in Brian's sinuses, believed to be a type of cancer called squamous cell. It was devastating, but as it was a holiday weekend, there weren't any specialist doctors who could help at the time.
Jodi explained that a generous ENT did a biopsy of the mass at the side of Brian's bed so they could get the ball rolling.
"He knew it was important to act fast because the tumor was so large," Jodi said. "Jersey Shore had a tough time with the biopsy because it was beyond their expertise, so a friend of ours hand-delivered it to Memorial Sloan Kettering Cancer Center in New York so we could move forward. Everyone knew time wasn't on our side, and Brian was deteriorating before our eyes."
The mass wasn't squamous cell, after all.
Brian and Jodi McNamara following the cancer diagnosis in 2024.
Brian and Jodi McNamara following the cancer diagnosis in 2024.
@wintheinch_wintheday / TikTok
On December 8, Brian was diagnosed with small cell neuroendocrine carcinoma, a rare and highly aggressive cancer. Brian and his family were devastated and heartbroken because they knew time was against them, and it wasn't going to be an easy road ahead.
"It was incredibly scary. Our whole lives changed at that moment. I cried and felt the floor drop from below us," Jodi said.
Developing a Treatment Plan
After transferring to the Memorial Sloan Kettering Cancer Center, Brian met with a medical oncologist and radiation oncologist who both stressed the importance of tackling his cancer quickly.
Within a day, he began chemotherapy, consisting of three consecutive days of treatment every three weeks for five rounds. Brian also did proton radiation twice a day for 15 days.
Because of how rare and dangerous the cancer is, the couple wanted to get as much information as possible and listen to as many experts as they could. So, they also traveled to Texas, Boston, and Maryland to build up a team of doctors who could help.
It's hoped that Brian can do immunotherapy treatment for a year, but if it comes back within that time, "there aren't many options" left. There is still so much uncertainty, and Brian constantly feels like he's in limbo waiting for some good news.
Every time he has another scan, Jodi and Brian are filled with dread about what could happen next.
Jodi told Newsweek: "He can't get excited about good news because we've been told it does come back usually in the first two years. I'm terrified that we will be faced with our worst nightmare, and we will lose Brian."
Brian McNamara after receiving proton treatment for his rare cancer.
Brian McNamara after receiving proton treatment for his rare cancer.
@wintheinch_wintheday / TikTok
Sharing the Journey Online
As a teacher and football coach, Brian has long instilled a specific message into his students: "win the inch, win the day."
Now, that's the motto he's living by. He continues to fight for his family, loved ones, and the community of friends and neighbors who have rallied around him since his diagnosis.
Jodi has been documenting his journey on TikTok (@wintheinch_wintheday) to raise awareness for Brian's rare type of cancer. Many of the posts have gone viral, with one even amassing more than 1.5 million views on TikTok at the time of writing.
While standing by her husband's side, Jodi used social media "out of desperation" to find others who have dealt with this firsthand. It was a useful way to gain information, but as it evolved, they developed a supportive community on TikTok. Jodi has also documented the difficulties they've faced with insurance companies refusing to help.
Brian continues to fight this rare cancer with everything he's got, and he's been so overwhelmed by the love he's received—both online and in person.
"Before we left for his treatment, the town came together for a car parade. The roads were closed and hundreds of cars met at the school and formed a line to drive by our home. It was so emotional and eye-opening how appreciated he is. Brian was so overwhelmed and said that was his push to fight because he was determined not to let them down," Jodi said.
Is there a health issue that's worrying you? Let us know via health@newsweek.com. We can ask experts for advice, and your story could be featured on Newsweek.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Tom's Guide
2 hours ago
- Tom's Guide
I swapped the StairMaster for hill running — here's what it did for my mind and body
The StairMaster is a popular gym machine that offers a hefty lower-body workout. On those revolving steps, you build strength in your quads, glutes, and calves while challenging your cardio and burning calories. That's all fine and well until you get bored three minutes in, staring at the plain white gym wall in front of you, wishing you had downloaded something on Netflix to pass the time as you count down the remaining steps. There are certainly ways to spice up your StairMaster sessions; for example, my colleague Sam tried the 25-7-2 TikTok workout for a week. The challenge involves setting your StairMaster to level seven, stepping for 25 minutes, and completing the workout twice a week. But I'm a sunshine worshipper, and if I can work out outdoors instead of indoors, I will. So, while trying to figure out how I could get benefits similar to those offered by StairMaster, I decided to ditch the StairMaster and the gym altogether and take to my local hills to work out. Here's what happened. I felt a bit like a grandma saying 'technology is great, isn't it,' but it really did help when I started looking for good hill running spots. After moving to my new area, I used Strava's route maps (part of its premium features) and played around with filters like elevation and distance to find hilly routes other local runners were using. For my first session, I didn't follow a set plan. I just wanted to see how I handled the elevation. If you already know your local hills, you could turn them into a short workout, like a set of sprints with jog-back recoveries. It sounds a bit cliché, but I genuinely feel a rush when running up a steep hill, surrounded by greenery with even bigger hills looming in the background. Breathing in fresh air instead of the recycled, sweaty air from the gym is also a huge bonus. Hill running is undeniably hard, but being outdoors helps to distract you from how tough it is. Plus, it's easier to take walking breaks without messing around with machine settings. You can just ease off when you need to and get going again when you're ready. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. I know I'm lucky to live right at the foot of some scenic hills, and not everyone will have easy access to this. But you definitely don't need to live near mountains to give hill running a go. A steeper path in your local park can work just as well, and apps like Strava are great for spotting popular hill routes nearby. If you're heading off-road like I did, I'd highly recommend wearing a pair of the best trail running shoes for adding grip and stability on uneven ground. The Hoka Speedgoat 6 is built for rugged terrain, with grippy soles that keep you stable on uneven trails and a cushioned feel that helps soften steep climbs and descents. They're light, comfortable, and designed to handle hills with confidence. Just like the stairmaster, hill running really puts your glutes to work. It mainly activates the gluteus maximus, which plays a key role in hip extension and powering you forward as you climb. The steeper the gradient, the harder those muscles fire to keep you moving. I usually notice it the day after, not an overwhelming soreness, but a solid, satisfying ache that feels like progress. In short, hill running is a practical way to build glute strength using just your body and the terrain. Hill running is not just a tough workout but one with real benefits. A recent study published in the Journal of Sports Sciences looked at hill runners' fitness, body composition, and performance. It found that better aerobic capacity and lower body fat were linked to stronger hill running performance. The study also noted that hill running pushes you close to your maximum effort, which is a sign of an effective cardiovascular workout. However, it's important to note that another key takeaway from the study was that many hill runners might be burning more energy than they take in, so fueling properly is important if you increase your hill running sessions. Follow Tom's Guide on Google News to get our up-to-date news, how-tos, and reviews in your feeds. Make sure to click the Follow button.
Newsweek
4 hours ago
- Newsweek
FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The U.S. Food and Drug Administration (FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational gene therapy trials for limb girdle muscular dystrophy following three patient deaths potentially linked to the company's treatments. The agency announced the action on Friday, citing serious safety concerns and "unreasonable and significant risk" to study participants. The FDA also revoked the company's platform technology designation and requested Sarepta voluntarily halt shipments of its approved drug Elevidys, which the company refused to do. Newsweek reached out to Sarepta Therapeutics via email on Sunday after normal business hours for comment. Why It Matters This regulatory intervention represents a significant safety measure in the gene therapy field, affecting both ongoing clinical trials and an already approved treatment for Duchenne muscular dystrophy. The decision could impact treatment options for families dealing with these devastating muscle-wasting diseases. Duchenne muscular dystrophy is a rare and serious genetic condition that worsens over time, leading to weakness and wasting away of the body's muscles. What To Know The three deaths resulted from acute liver failure in patients treated with either Elevidys or investigational therapies using the same AAVrh74 viral vector technology. One fatality occurred during a clinical trial for limb girdle muscular dystrophy treatment. Elevidys is an adeno-associated virus vector-based gene therapy designed to deliver a gene that leads to production of a shortened protein that contains selected domains of the dystrophin protein present in normal muscle cells. The disease occurs due to a defective gene that results in abnormalities in, or absence of, dystrophin, a protein that helps keep the body's muscle cells intact. The drug received traditional approval for ambulatory DMD patients aged 4 and older on June 20, 2024, while maintaining accelerated approval for non-ambulatory patients since June 22, 2023. Under accelerated approval, companies must conduct confirmatory studies to verify clinical benefit. Given the new safety concerns, the FDA has notified Sarepta that the drug's indication should be restricted to ambulatory patients only. The FDA revoked the platform technology designation for Sarepta's AAVrh74 Platform Technology because the preliminary evidence is insufficient to demonstrate that the technology has the potential to be incorporated in multiple drugs without adverse safety effects. What People Are Saying FDA Commissioner Marty Makary, M.D., M.P.H.: "Today, we've shown that this FDA takes swift action when patient safety is at risk. We believe in access to drugs for unmet medical needs but are not afraid to take immediate action when a serious safety signal emerges." Dr. Vinay Prasad, Director of FDA's Center for Biologics Evaluation and Research: "Protecting patient safety is our highest priority, and the FDA will not allow products whose harms are greater than benefits. The FDA will halt any clinical trial of an investigational product if clinical trial participants would be exposed to an unreasonable and significant risk of illness or injury." FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, Tuesday, April 22, 2025. FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, Tuesday, April 22, 2025. AP Photo/Jose Luis Magana, File What Happens Next The FDA will continue investigating the risk of acute liver failure and other serious outcomes following gene therapies using Sarepta's AAVrh74 platform technology. The agency has committed to taking additional regulatory actions as needed to protect patients. For current Elevidys patients, the FDA is focusing its safety investigation on ambulatory patients while restricting the drug's use in non-ambulatory patients.
Newsweek
13 hours ago
- Newsweek
Millennial Man Told He Has Sinus Infection, Then Doctors Drop a Bombshell
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A man's life has been derailed after what seemed like a sinus infection turned out to be a devastating diagnosis that would leave him fighting for his life. In 2024, Brian McNamara, 47, thought he'd developed a sinus infection because he had persistent symptoms that he couldn't shake for months. The teacher and football coach from New Jersey developed a sinus headache that continued to get worse as the months went by. As it progressed, his symptoms escalated and became numerous. Hardly a day went by when he didn't feel in pain or discomfort. McNamara's wife, Jodi, told Newsweek that, after a while, he went to urgent care where he was treated "for a sinus infection." Nonetheless, the symptoms persisted, and treatment wasn't working. "It continued to worsen, and he started having ringing in his ears, a fullness feeling in the ears (like he was underwater), bad breath, neck pain, and jaw tightness," Jodi, 44, said. "Then, he got eventual facial numbness and double vision too. Brian and Jodi McNamara pictured together in a hospital. Brian and Jodi McNamara pictured together in a hospital. @wintheinch_wintheday / TikTok "It went from bad to worse two weeks prior to Thanksgiving, but looking back now, it was probably June when his symptoms started," she continued. Given how bad his symptoms were, Brain returned to the ER after Thanksgiving. He was taken for an MRI and CT scan, which is when everything changed. A mass was discovered in Brian's sinuses, believed to be a type of cancer called squamous cell. It was devastating, but as it was a holiday weekend, there weren't any specialist doctors who could help at the time. Jodi explained that a generous ENT did a biopsy of the mass at the side of Brian's bed so they could get the ball rolling. "He knew it was important to act fast because the tumor was so large," Jodi said. "Jersey Shore had a tough time with the biopsy because it was beyond their expertise, so a friend of ours hand-delivered it to Memorial Sloan Kettering Cancer Center in New York so we could move forward. Everyone knew time wasn't on our side, and Brian was deteriorating before our eyes." The mass wasn't squamous cell, after all. Brian and Jodi McNamara following the cancer diagnosis in 2024. Brian and Jodi McNamara following the cancer diagnosis in 2024. @wintheinch_wintheday / TikTok On December 8, Brian was diagnosed with small cell neuroendocrine carcinoma, a rare and highly aggressive cancer. Brian and his family were devastated and heartbroken because they knew time was against them, and it wasn't going to be an easy road ahead. "It was incredibly scary. Our whole lives changed at that moment. I cried and felt the floor drop from below us," Jodi said. Developing a Treatment Plan After transferring to the Memorial Sloan Kettering Cancer Center, Brian met with a medical oncologist and radiation oncologist who both stressed the importance of tackling his cancer quickly. Within a day, he began chemotherapy, consisting of three consecutive days of treatment every three weeks for five rounds. Brian also did proton radiation twice a day for 15 days. Because of how rare and dangerous the cancer is, the couple wanted to get as much information as possible and listen to as many experts as they could. So, they also traveled to Texas, Boston, and Maryland to build up a team of doctors who could help. It's hoped that Brian can do immunotherapy treatment for a year, but if it comes back within that time, "there aren't many options" left. There is still so much uncertainty, and Brian constantly feels like he's in limbo waiting for some good news. Every time he has another scan, Jodi and Brian are filled with dread about what could happen next. Jodi told Newsweek: "He can't get excited about good news because we've been told it does come back usually in the first two years. I'm terrified that we will be faced with our worst nightmare, and we will lose Brian." Brian McNamara after receiving proton treatment for his rare cancer. Brian McNamara after receiving proton treatment for his rare cancer. @wintheinch_wintheday / TikTok Sharing the Journey Online As a teacher and football coach, Brian has long instilled a specific message into his students: "win the inch, win the day." Now, that's the motto he's living by. He continues to fight for his family, loved ones, and the community of friends and neighbors who have rallied around him since his diagnosis. Jodi has been documenting his journey on TikTok (@wintheinch_wintheday) to raise awareness for Brian's rare type of cancer. Many of the posts have gone viral, with one even amassing more than 1.5 million views on TikTok at the time of writing. While standing by her husband's side, Jodi used social media "out of desperation" to find others who have dealt with this firsthand. It was a useful way to gain information, but as it evolved, they developed a supportive community on TikTok. Jodi has also documented the difficulties they've faced with insurance companies refusing to help. Brian continues to fight this rare cancer with everything he's got, and he's been so overwhelmed by the love he's received—both online and in person. "Before we left for his treatment, the town came together for a car parade. The roads were closed and hundreds of cars met at the school and formed a line to drive by our home. It was so emotional and eye-opening how appreciated he is. Brian was so overwhelmed and said that was his push to fight because he was determined not to let them down," Jodi said. Is there a health issue that's worrying you? Let us know via health@ We can ask experts for advice, and your story could be featured on Newsweek.
